Recent lessons learned from prevention and recent-onset type 1 diabetes immunotherapy trials

Diabetes. 2013 Jan;62(1):9-17. doi: 10.2337/db12-0562.

Authors

Teodora P Staeva¹, Lucienne Chatenoud, Richard Insel, Mark A Atkinson

Affiliation

¹ JDRF, New York, New York, USA.

No abstract available

Publication types

Review

MeSH terms

Autoantigens / immunology
Clinical Trials as Topic
Diabetes Mellitus, Type 1 / immunology
Diabetes Mellitus, Type 1 / prevention & control*
Diabetes Mellitus, Type 1 / therapy*
Humans
Immunosuppressive Agents / therapeutic use
Immunotherapy*
Insulin-Secreting Cells / immunology
Research Design

Substances

Autoantigens
Immunosuppressive Agents